Description

Welcure Drugs & Pharmaceuticals Limited has allotted 11,23,58,200 bonus shares in the ratio of 1:10 (post share split from Rs. 10 to Re. 1 face value), with listing effective from October 20, 2025.

Summary

Welcure Drugs & Pharmaceuticals Limited (Scrip Code: 524661, ISIN: INE331C01025) has completed the allotment of bonus shares. The company allotted 11,23,58,200 new equity shares of Re. 1 face value each on October 17, 2025, in the ratio of 1:10. This bonus issue was approved by the Board of Directors on August 22, 2025, and by shareholders on September 27, 2025. The allotment takes into account a share split from Rs. 10 to Re. 1 face value per share.

Key Points

  • Company allotted 11,23,58,200 bonus equity shares of Re. 1 face value each
  • Bonus ratio: 1:10 (one bonus share for every 10 shares held)
  • Pre-allotment issued capital: 1,12,35,82,000 equity shares of Re. 1 each
  • Post-allotment issued capital: 1,23,59,40,200 equity shares of Re. 1 each
  • Share split executed from Rs. 10 face value to Re. 1 face value
  • Distribution number range for new shares: 1,12,35,82,001 to 1,23,59,40,200
  • No shares kept in abeyance or pending for listing
  • Contact person: Chintan Didawala Ganpat, Managing Director

Regulatory Changes

No regulatory changes. This is a standard corporate action under existing SEBI regulations for bonus issues and share splits.

Compliance Requirements

  • Company has revised Annexure I to reflect the share split effect
  • Updated share count from 11,235,820 to 112,358,200 shares post-split
  • Face value updated from Rs. 10.00 to Re. 1.00 per share
  • All statutory approvals obtained from Board of Directors and shareholders

Important Dates

  • August 22, 2025: Board of Directors approved bonus issue
  • September 27, 2025: Shareholders approved bonus issue
  • October 17, 2025: Date of allotment of bonus shares
  • October 20, 2025: Effective date of listing of bonus shares

Impact Assessment

Shareholder Impact: Existing shareholders receive one additional share for every 10 shares held, increasing their shareholding by 10% while maintaining proportionate ownership. The share split from Rs. 10 to Re. 1 improves affordability and may enhance liquidity.

Market Impact: The bonus issue increases the total share count by 10%, which may improve market liquidity. Combined with the 10:1 share split, the lower face value makes shares more accessible to retail investors. No dilution of ownership as bonus shares are issued proportionately.

Capital Structure Impact: Total issued and paid-up capital increases from Rs. 112.36 crores to Rs. 123.59 crores, though this is capitalization of reserves with no fresh capital infusion. The revised capital structure reflects both the bonus issue and share split adjustments.

Impact Justification

Standard corporate action involving bonus issue combined with share split. Significant for existing shareholders with 10% increase in shareholding. Medium impact as it affects share structure and liquidity.